# GNPS Untargeted GC‐MS Metabolomic Analysis of Essential Oils From Duguetia lanceolata and Evaluation of Antimicrobial Activity

**Authors:** Jackson Monteiro, Geovanna N. Antonelli, Erick P. Dantas, Simone S. Grecco, Marisi G. Soares, João Henrique G. Lago, Renata C. Pascon, Marcelo A. Vallim, Patricia Sartorelli

PMC · DOI: 10.1002/cbdv.202503280 · Chemistry & Biodiversity · 2026-02-25

## TL;DR

This study analyzed essential oils from Duguetia lanceolata leaves collected in different seasons and found they have different chemical compositions and antimicrobial properties.

## Contribution

The study introduces a GNPS untargeted GC-MS approach to compare seasonal variations in essential oil composition and antimicrobial activity of Duguetia lanceolata.

## Key findings

- Autumn essential oils contained monoterpenes like limonene, while winter oils were rich in sesquiterpenes like β-bisabolene.
- Autumn essential oils showed stronger antimicrobial activity against bacteria and yeast compared to winter oils.
- Molecular docking suggested that limonene and β-bisabolene bind to key enzymes in bacteria and fungi, explaining their antimicrobial effects.

## Abstract

In this study, the chemical composition of essential oils (EOs) extracted from leaves of Duguetia lanceolata collected in different seasons (autumn and winter) was analyzed using a GNPS untargeted GC‐MS metabolomic approach. EO from autumn leaves (EO‐A) contained 80 metabolites (93.8%), with limonene (28.5%), (+)‐β‐pinene (15.0%), cyclocolorenone (12.8%), 6,9‐guaiadiene (3.1%), and 4‐carvomenthenol (3.1%) as major constituents. EO from winter leaves (EO‐W) comprised 102 compounds (88.0%), dominated by β‐bisabolene (16.4%), β‐gurjunene (6.4%), β‐caryophyllene (4.7%), cyclocolorenone (3.9%), and dihydrocarveol (3.3%). The antimicrobial activity of both EOs was evaluated in vitro using the disk diffusion method against gram‐positive and gram‐negative bacteria, as well as selected yeast strains. MIC values ranged from 0.016 to 0.270 µg·mL−
1, with EO‐A generally exhibiting lower MICs than EO‐W. EO‐A was active against Acinetobacter baumannii, Candida krusei, and Candida parapsilosis, whereas EO‐W showed no activity against these strains. Complementary in silico analyses supported these findings: PASS predictions suggested potential antibacterial and antifungal activity for the major constituents, and molecular docking indicated favorable binding of limonene and β‐bisabolene to DNA gyrase B (A. baumannii) and lanosterol 14α‐demethylase (CYP51, C. albicans), providing a mechanistic rationale for the observed antimicrobial effects. These results highlight the importance of seasonal collection in optimizing the bioactive potential of D. lanceolata leaves.

Untargeted metabolomic analysis of the essential oil of D. lanceolata leaves collected in winter revealed that they are mostly composed of sesquiterpenes, while those collected in autumn showed a predominance of monoterpenes. Both essential oils displayed antimicrobial activity against bacterial and fungal species. All graphical elements were created using BioRender.com.

## Linked entities

- **Chemicals:** limonene (PubChem CID 22311), β-pinene (PubChem CID 440967), cyclocolorenone (PubChem CID 160491), 6,9-guaiadiene (PubChem CID 527113), 4-carvomenthenol (PubChem CID 11230), β-bisabolene (PubChem CID 403919), β-caryophyllene (PubChem CID 5281515), dihydrocarveol (PubChem CID 12072)
- **Species:** Duguetia lanceolata (taxon 2072239), Acinetobacter baumannii (taxon 470), Candida albicans (taxon 5476)

## Full-text entities

- **Genes:** CYP1A2 (cytochrome P450 family 1 subfamily A member 2) [NCBI Gene 1544] {aka CP12, CYPIA2, P3-450, P450(PA)}, CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}, CYP2C9 (cytochrome P450 family 2 subfamily C member 9) [NCBI Gene 1559] {aka CPC9, CYP2C, CYP2C10, CYPIIC9, P450-2C9, P450IIC9}, CYP51A1 (cytochrome P450 family 51 subfamily A member 1) [NCBI Gene 1595] {aka CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}, CYP2C19 (cytochrome P450 family 2 subfamily C member 19) [NCBI Gene 1557] {aka CPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19}
- **Diseases:** death (MESH:D003643), back pains (MESH:D001416), nosocomial infections (MESH:D003428), toxicity (MESH:D064420), rheumatism (MESH:D012216), infections (MESH:D007239), bacterial infections (MESH:D001424), stomach, kidney, (MESH:D007674), fungal (MESH:D009181), inflammatory (MESH:D007249), AMR (MESH:D060467), EO-A (MESH:D055191)
- **Chemicals:** (E)-caryophyllene (MESH:C024714), ALA187 (-), 4-carvomenthenol (MESH:C534301), carvacrol (MESH:C073316), beta-Bisabolene (MESH:C531191), Helium (MESH:D006371), quinolones (MESH:D015363), 2,4,5-trimethoxystyrene (MESH:C056257), caryophyllene oxide (MESH:C515179), pinane (MESH:C030216), monoterpene (MESH:D039821), Oils (MESH:D009821), HEM A (MESH:C005044), Na2SO4 (MESH:C012036), cephalosporins (MESH:D002511), amphotericin B (MESH:D000666), heme (MESH:D006418), lipopolysaccharide (MESH:D008070), lipid (MESH:D008055), sesquiterpene (MESH:D012717), beta-eudesmol (MESH:C051082), ampicillin (MESH:D000667), fluconazole (MESH:D015725), caspofungin (MESH:D000077336), diethyl ether (MESH:D004986), D-glucose (MESH:D005947), Eugenol (MESH:D005054), DMSO (MESH:D004121), beta-lactams (MESH:D047090), p-cymene (MESH:C007210), beta-elemene (MESH:C445979), spathulenol (MESH:C013258), aminoglycosides (MESH:D000617), dihydrocarveol (MESH:C534305), caryophyllane (MESH:D000081223), azole (MESH:D001393), Limonene (MESH:D000077222), agar (MESH:D000362), aristolochene (MESH:C054277), beta-gurjunene (MESH:C087929), carbapenems (MESH:D015780), EO (MESH:D009822), gamma-terpinene (MESH:C018669), terpene (MESH:D013729), methylene blue (MESH:D008751), cyclic hydrocarbons (MESH:D006844), alpha-pinene (MESH:C005451), (+)-beta-pinene (MESH:C010789), germacrene D (MESH:C027259), kanamycin (MESH:D007612), C15 (MESH:C003946), thymol (MESH:D013943), cyclocolorenone (MESH:C007186), beta-selinene (MESH:C087920)
- **Species:** Lodderomyces parapsilosis (species) [taxon 5480], Litsea cubeba (aromatic litsea, species) [taxon 155299], Melaleuca alternifolia (tea tree, species) [taxon 164405], Duguetia lanceolata (species) [taxon 2072239], Homo sapiens (human, species) [taxon 9606], Syzygium aromaticum (clove, species) [taxon 219868], Duguetia furfuracea (species) [taxon 1563425], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Acinetobacter baumannii (species) [taxon 470], Sitophilus zeamais (maize weevil, species) [taxon 7047], Zabrotes subfasciatus (Mexican bean weevil, species) [taxon 122865], Eucalyptus camaldulensis (Murray red gum, species) [taxon 34316], Enterococcus faecium (species) [taxon 1352], Duguetia quitarensis (species) [taxon 294164], Escherichia coli (E. coli, species) [taxon 562], Myrtus communis (species) [taxon 119949], Pichia kudriavzevii (species) [taxon 4909], Drepanidotaenia lanceolata (species) [taxon 1732538], Candida albicans (species) [taxon 5476], Klebsiella pneumoniae (species) [taxon 573], Dimorphandra gardneriana (species) [taxon 1954554], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Pseudomonas aeruginosa (species) [taxon 287], Cryptococcus neoformans (Cryptococcus neoformans serotype A, species) [taxon 5207], Cinnamomum verum (Ceylon cinnamon, species) [taxon 128608], Streptococcus pyogenes (species) [taxon 1314], Enterobacter (genus) [taxon 547], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Cell lines:** JEC21 — Mus musculus (Mouse), Hybridoma (CVCL_C5HW), R265 — Mus musculus (Mouse), Hybridoma (CVCL_J809), NIH312 — Homo sapiens (Human), Mucopolysaccharidosis type IIIA, Finite cell line (CVCL_0L91), ATCC 25923 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935287/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935287/full.md

## References

87 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935287/full.md

---
Source: https://tomesphere.com/paper/PMC12935287